The impact of smoking status on the progression‐free survival of non‐small cell lung cancer patients receiving molecularly target therapy or immunotherapy versus chemotherapy: A meta‐analysis-Reference-Cited by-同舟云学术

The impact of smoking status on the progression‐free survival of non‐small cell lung cancer patients receiving molecularly target therapy or immunotherapy versus chemotherapy: A meta‐analysis

Published:2020-11-05 Issue:2 Volume:46 Page:256-266
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Li Xinyi¹^ORCID,Huang Cong¹,Xie Xiaohui¹²,Wu Ziyang¹^ORCID,Tian Xia²,Wu Yibo¹,Du Xin¹,Shi Luwen¹²

Affiliation:

1. Department of Pharmacy Administration and Clinical Pharmacy School of Pharmaceutical Sciences Peking University Beijing China

2. International Research Center for Medicinal Administration Peking University Beijing China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13309

Reference39 articles.

1. Colorectal cancer statistics, 2020

2. The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes

3. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy

4. Impact of smoking on lung cancer treatment effectiveness: a review

5. Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the Influence of Lifestyle Factors on Immunotherapy Efficacy in Cancer Patients;Handbook of Cancer and Immunology;2024

2. How do self-exempt beliefs affect intentions to quit smoking? An exploration of the mediating role of threat appraisal and coping appraisal;Frontiers in Psychology;2023-11-30

3. Pembrolizumab monotherapy for non-small cell lung cancer (NSCLC): can patient stratification be improved in the UK Tayside population? A retrospective cohort study;BMJ Open;2023-11

4. Targeting Pokemon is a novel strategy to suppress cancer aggressiveness of non-small cell lung cancer: Identification of Pokemon as ideal target for developing anti-NSCLC drugs;Archives of Biochemistry and Biophysics;2023-07

5. Personal and clinical characteristics associated with immunotherapy effectiveness in stage IV non-small cell lung cancer;Translational Lung Cancer Research;2023-06